2024-10-27-PitchBook-PitchBook年肿瘤健康科技VC市场快照（英）_20页_20mb

EMERGING TECH RESEARCH: ONCOLOGY HEALTHTECH VC MARKET SNAPSHOT 2024

Market Overview:

• Cancer Prevalence and Costs: Cancer ranks as a leading cause of global mortality, with widening economic costs due to increasing cases and treatment expenses. While mortality rates have improved, further reductions are challenging.
• Market Size: The global oncology healthtech market is estimated at ~$250 billion, with a key opportunity in cancer screening ($100B globally) and potential growth from liquid biopsies.
• VC Activity: Oncology healthtech startups raised ~$16B since 2020. Activity peaked in 2021 and declined in 2023, though 2024 shows signs of recovery with ~$2.8B invested so far. VC investment concentration is in diagnostics/precision oncology, with notable companies including Freenome and Insightec.

Opportunities:

• Blood-Based Screening (Liquid Biopsies): High potential for early detection and personalized treatment; global addressable market could exceed $100B by 2034. Key players include Freenome and Singlera Genomics.
• Interventional Oncology: Minimally invasive solutions for treating cancer with reduced patient impact; growing funding but adoption challenges remain.
• Surgical Innovation: Robotic-assisted and novel imaging technologies support more precise tumor detection and treatment.

Risks and Considerations:

• Screening Challenges: Tests must balance sensitivity and specificity to avoid high false positive rates, which increase costs and lead times.
• Payer Barriers: Payers scrutinize the cost-benefit of screening tests, especially those with high upfront costs.
• AI Disruption: AI-powered diagnostics threaten traditional approaches; startups must invest continually in innovation.

Market Segmentation:
VC-backed companies are categorized into:

• Diagnostics & Life Sciences: Covers screening, precision oncology, and research tools.
• Treatment & Care: Includes surgical aids, drug delivery, and post-treatment devices.
• Digital Health & Healthcare IT: Leverages AI for analysis, telehealth services, and care coordination.